Tocilizumab for severe COVID-19: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

Tocilizumab for severe COVID-19: a systematic review and meta-analysis

Published:2020-09 Issue:3 Volume:56 Page:106103
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Lan Shao-Huan,Lai Chih-Cheng,Huang Hui-Ting,Chang Shen-Peng,Lu Li-Chin,Hsueh Po-Ren

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference27 articles.

1. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges;Lai;Int J Antimicrob Agents,2020

2. Global coronavirus disease 2019: what has daily cumulative index taught us?;Lai;Int J Antimicrob Agents,2020

3. World Health Organization (WHO). Coronavirus disease (COVID-19) pandemic. https://www.who.int/emergencies/diseases/novel-coronavirus-2019[accessed 26 May 2020].

4. Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): facts and myths;Lai;J Microbiol Immunol Infect,2020

5. Clinical characteristics of coronavirus disease 2019 in China;Guan;N Engl J Med,2020

Cited by 141 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigating the impact of Tocilizumab, Sarilumab, and Anakinra on clinical outcomes in COVID-19: A systematic review and meta-analysis;IJC Heart & Vasculature;2024-10

2. The Role of Immunomodulatory Therapy with Oxiris in COVID-19 with Renal Failure and Immune Dysfunction;Blood Purification;2024-07-22

3. Innovative Formulation Platform: Paving the Way for Superior Protein Therapeutics with Enhanced Efficacy and Broadened Applications;Advanced Materials;2024-06-16

4. Comparison of ELISA with automated ECLIA for IL-6 determination in COVID-19 patients: An Italian real-life experience;Practical Laboratory Medicine;2024-03

5. The role of clinical and immunological parameters in predicting the effectiveness of additional immunotropic therapy in oxygen-dependent patients with COVID-19 coronavirus disease;Pathologia;2023-12-22